Cellosaurus logo
expasy logo

Cellosaurus A-204/PazR (CVCL_QY41)

[Text version]
Cell line name A-204/PazR
Synonyms PazR/A204
Accession CVCL_QY41
Resource Identification Initiative To cite this cell line use: A-204/PazR (RRID:CVCL_QY41)
Comments Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI:71219; Pazopanib (Votrient).
Omics: Deep phosphoproteome analysis.
Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
Sequence variations
  • Mutation; HGNC; 11103; SMARCB1; Simple; p.Gln182Alafs*28 (c.543_544delTC); Zygosity=Heterozygous (from parent cell line).
Disease Embryonal rhabdomyosarcoma (NCIt: C8971)
Embryonal rhabdomyosarcoma (ORDO: Orphanet_99757)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1058 (A-204)
Sex of cell Female
Age at sampling 1Y
Category Cancer cell line
Publications

PubMed=28842319; DOI=10.1016/j.jprot.2017.08.015; PMCID=PMC5673060
Vyse S., McCarthy F., Broncel M., Paul A., Wong J.P., Bhamra A., Huang P.H.
Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib.
J. Proteomics 170:130-140(2018)

Cross-references
Encyclopedic resources Wikidata; Q54605983
Proteomic databases PRIDE; PXD005536
Entry history
Entry creation05-Mar-2018
Last entry update05-Oct-2023
Version number7